You are here

Article Text

Article menu

Download PDFPDF

LUNG ALERT
Cardioselective β blockers do not cause adverse respiratory effects in mild to moderate reactive airway disease
Free
  1. E Gamble
  1. lizgamble@cwcom.net

https://doi.org/10.1136/thorax.58.2.142

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective β blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med2002;137:715–25
    OpenUrlCrossRefPubMedWeb of Science

    This study examined data from 19 studies of single dose treatment and 10 studies of continued treatment with cardioselective β blockers (atenolol, metoprolol, bisoprolol, practolol, celiprolol, acebutolol and xamoterol) in patients …

    View Full Text